These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7940563)

  • 1. Use of animal studies in risk assessment for immunotoxicology.
    Luster MI; Portier C; Pait DG; Germolec DR
    Toxicology; 1994 Sep; 92(1-3):229-43. PubMed ID: 7940563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests.
    Luster MI; Portier C; Pait DG; Rosenthal GJ; Germolec DR; Corsini E; Blaylock BL; Pollock P; Kouchi Y; Craig W
    Fundam Appl Toxicol; 1993 Jul; 21(1):71-82. PubMed ID: 8365588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests.
    Luster MI; Portier C; Pait DG; White KL; Gennings C; Munson AE; Rosenthal GJ
    Fundam Appl Toxicol; 1992 Feb; 18(2):200-10. PubMed ID: 1534777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology.
    Luster MI; Pait DG; Portier C; Rosenthal GJ; Germolec DR; Comment CE; Munson AE; White K; Pollock P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():71-8. PubMed ID: 1471226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of animal tests in risk assessment for immunotoxicology.
    Luster MI; Portier C; Pait DG; Germolec DR
    Toxicol In Vitro; 1994 Oct; 8(5):945-50. PubMed ID: 20693051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing strategies in immunotoxicology.
    Pallardy M; Kerdine S; Lebrec H
    Toxicol Lett; 1998 Dec; 102-103():257-60. PubMed ID: 10022262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental immunotoxicology and risk assessment: a workshop summary.
    Holsapple MP
    Hum Exp Toxicol; 2002; 21(9-10):473-8. PubMed ID: 12458903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the prospects for regulation in immunotoxicology?
    Hastings KL
    Toxicol Lett; 1998 Dec; 102-103():267-70. PubMed ID: 10022264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of extended histopathology to detect immunotoxic chemicals.
    Germolec DR; Kashon M; Nyska A; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Dec; 82(2):504-14. PubMed ID: 15342959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of immunotoxicity: from animal studies to human biomonitoring.
    Van Loveren H; Steerenberg PA; Vos JG
    Toxicol Lett; 1995 May; 77(1-3):73-80. PubMed ID: 7618171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo methods in immunotoxicology.
    Krakowka S
    Toxicol Pathol; 1987; 15(3):276-80. PubMed ID: 3685788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential future requirements for immunotoxicology testing of pesticides.
    Sjoblad RD
    Toxicol Ind Health; 1988 Sep; 4(3):391-5. PubMed ID: 3176044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.
    Kaplan BL; Li J; LaPres JJ; Pruett SB; Karmaus PW
    Toxicol Sci; 2015 Jun; 145(2):214-32. PubMed ID: 26008184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20 Years of fish immunotoxicology - what we know and where we are.
    Rehberger K; Werner I; Hitzfeld B; Segner H; Baumann L
    Crit Rev Toxicol; 2017 Jul; 47(6):509-535. PubMed ID: 28425344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental Immunotoxicology and Risk Assessment. Proceedings of a workshop. 12-13 June 2001, Washington, DC, USA.
    Hum Exp Toxicol; 2002; 21(9-10):469-572. PubMed ID: 12458902
    [No Abstract]   [Full Text] [Related]  

  • 16. The rat as a model in developmental immunotoxicology.
    Smialowicz RJ
    Hum Exp Toxicol; 2002; 21(9-10):513-9. PubMed ID: 12458909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the rat in developmental immunotoxicology studies.
    Chapin RE
    Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mouse as a model for developmental immunotoxicology.
    Holladay SD; Blaylock BL
    Hum Exp Toxicol; 2002; 21(9-10):525-31. PubMed ID: 12458911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment and immunotoxicology.
    Van Loveren H; De Jong WH; Vandebriel RJ; Vos JG; Garssen J
    Toxicol Lett; 1998 Dec; 102-103():261-5. PubMed ID: 10022263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.